Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

10.38
+0.54005.49%
Post-market: 10.15-0.2300-2.22%19:30 EDT
Volume:604.02K
Turnover:6.15M
Market Cap:200.76M
PE:-1.70
High:10.42
Open:9.97
Low:9.90
Close:9.84
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.33
T/O Rate:3.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.96
PE(LYR):-1.76

Loading ...

Corbus Pharma director Winston Kung reports disposal of 2,026 common shares worth $16,026.85

Reuters
·
Jun 12

Corbus Pharma director Anne Altmeyer disposes of 2,412 shares worth $19,085.82

Reuters
·
Jun 12

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 10

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 06

Corbus Pharmaceuticals Holdings Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Jun 05

Top Corbus Pharmaceuticals Executive Quietly Makes a Bold Insider Move

TIPRANKS
·
Jun 04

Corbus Chief Business Officer Nishant Saxena acquires $101,115 of common shares

Reuters
·
Jun 04

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 03

Corbus Pharmaceuticals (CRBP) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 02

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jasper Therapeutics (JSPR) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 02

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 28

Wedbush Sticks to Their Buy Rating for Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 27

Corbus Pharmaceuticals Holdings Inc : Wedbush Cuts Target Price to $30 From $38

THOMSON REUTERS
·
May 27

Corbus Pharmaceuticals Holdings Inc. Stock Slides 30.3%, Underperforms Peers

Dow Jones
·
May 27

Corbus Pharmaceuticals Falls on Reports of Adverse Events in Tumor-Treatment Study

Dow Jones
·
May 27

Corbus Pharmaceuticals share selloff overdone, says Guggenheim

TIPRANKS
·
May 27

Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 27

Corbus Pharmaceuticals Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 27